93 7702 Pill - red round
Pill with imprint 93 7702 is Red, Round and has been identified as Glimepiride and Rosiglitazone Maleate 4 mg / 8 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Glimepiride/rosiglitazone is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 4 mg / 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7702
Glimepiride and Rosiglitazone Maleate
- Imprint
- 93 7702
- Strength
- 4 mg / 8 mg
- Color
- Red
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7702
More about glimepiride / rosiglitazone
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
